SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 16, 2026

PCSA

Processa Pharmaceuticals, Inc.
BULLISH
Impact 4/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $9K total
Actionable Insight ▲ Bullish

The cluster buy by two C-suite officers at identical price and date is a modestly positive signal, but the company's $6M micro-cap, lack of revenue visibility, and historical pattern of insider buying providing no positive returns over 20 trading days warrant caution.

DirectionBullish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
PCSA ▼ -3.26% at T+60d
LONG call ✗ call lost -3.26% · α vs SPY -6.40% · entry $2.15 → $2.08
Entry = T+0 close
Jun 16, 2026
via day close
T+1d
-1.40%
call -1.40% · α -2.18%
$2.12
settled 4mo ago
T+5d
-10.23%
call -10.23% · α -9.19%
$1.93
settled 4mo ago
T+20d
+4.19%
call +4.19% · α +2.87%
$2.24
settled 3mo ago
T+60d
-3.26%
call -3.26% · α -6.40%
$2.08
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders at Processa Pharmaceuticals (PCSA) made small open-market purchases totaling ~$9K on June 15, 2026, at $2.22 per share.

Key Financial Metrics

Direction
buying
Total Value
$8.8K
Insiders
2

Key Facts

  • Chief Business & Strategy Officer Patrick Lin purchased 1,831 shares at $2.22 for $4,064.82 on June 15, 2026.
  • Chief Administrative Officer Wendy Guy purchased 2,118 shares at $2.22 for $4,701.96 on June 15, 2026.
  • Total cluster purchase value is $9K against a $6M market cap (~0.15%).
  • The two buys occurred on the same day at the same price, suggesting coordinated confidence rather than routine 10b5-1 selling.

Financial Impact

~$9K in total insider purchases, representing ~0.15% of the $6M market cap

dilutioninsider confidence

Risk Factors

  • Micro-cap with high bankruptcy risk; $6M market cap leaves minimal margin for error.
  • Open-market purchases of this size (~$4-5K per insider) could be routine portfolio adjustments, not conviction signals.
  • No 10b5-1 plan indicated, but the small dollar amount limits the signal's strength.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCSA-1781641299755
14 reports for PCSA
Performance horizon
70% Hit rate @ T+5 7 of 10 directional calls Went positive at some point 8 of 10 best @ T+5▲ +19.60%Mar 31, 2026
Filters
Rows
Reports for PCSA — sortable, filterable
TypeNow
Oct 26, 2026
today
EFFECT
BEARISH ★ 6/10
$1.81awaiting T+5—$1.79 (+0.83%)
Oct 22, 2026
4d ago
DEF 14A
NEUTRAL ★ 4/10
$1.81awaiting T+5—$1.79 (−0.83%)
Oct 9, 2026
17d ago
S-3
BEARISH ★ 7/10
$1.90 $1.73▲ +8.95%▲ +7.45%$1.79 (+5.53%)
Jul 29, 2026
12w ago
8-K
MIXED ★ 6/10
$2.03 $2.19▲ +7.88%▲ +2.35%$1.79 (−11.58%)
Jul 1, 2026
16w ago
Insider Cluster
BULLISH ★ 5/10
$2.16 $2.16· 0.00%▼ −1.37%$1.79 (−16.90%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 5/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.79 (−16.51%)
Jun 16, 2026
18w ago
Insider Cluster
BULLISH ★ 4/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.79 (−16.51%)
Jun 1, 2026
21w ago
Insider Cluster
BULLISH ★ 4/10
$2.92 $2.04▼ −30.31%▼ −27.34%$1.79 (−38.53%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.79 (−31.23%)
May 19, 2026
22w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.79 (−31.23%)
Showing 10 of 14

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 16, 2026